Patents by Inventor Barbara TROUPIN

Barbara TROUPIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS
    Publication number: 20230360760
    Abstract: The present invention provides methods for dispensing or distributing a drug, particularly a potentially teratogenic drug, to a patient while minimizing the occurrence of an adverse side effect. In particular, the present invention provides methods for dispensing or distributing a drug containing topiramate to a patient in need of weight loss to minimize the occurrence of potential birth defects associated with the drug. Methods for providing training to prescribers on the potential risks associated with particular drugs are also disclosed.
    Type: Application
    Filed: July 21, 2023
    Publication date: November 9, 2023
    Inventors: Michael MILLER, Barbara TROUPIN
  • METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS
    Publication number: 20220172814
    Abstract: The present invention provides methods for dispensing or distributing a drug, particularly a potentially teratogenic drug, to a patient while minimizing the occurrence of an adverse side effect. In particular, the present invention provides methods for dispensing or distributing a drug containing topiramate to a patient in need of weight loss to minimize the occurrence of potential birth defects associated with the drug. Methods for providing training to prescribers on the potential risks associated with particular drugs are also disclosed.
    Type: Application
    Filed: February 15, 2022
    Publication date: June 2, 2022
    Inventors: Michael MILLER, Barbara TROUPIN
  • METHODS OF PREVENTING PROGRESSION TO TYPE 2 DIABETES MELITUS
    Publication number: 20220031655
    Abstract: The present invention provides compositions and methods for delaying or preventing progression to type 2 diabetes mellitus in individuals with prediabetes and metabolic syndrome.
    Type: Application
    Filed: October 15, 2021
    Publication date: February 3, 2022
    Inventors: Wesley DAY, Barbara TROUPIN
  • METHODS OF PREVENTING PROGRESSION TO TYPE 2 DIABETES MELITUS
    Publication number: 20200179332
    Abstract: The present invention provides compositions and methods for delaying or preventing progression to type 2 diabetes mellitus in individuals with prediabetes and metabolic syndrome.
    Type: Application
    Filed: January 3, 2020
    Publication date: June 11, 2020
    Inventors: Wesley DAY, Barbara TROUPIN
  • METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS
    Publication number: 20200135318
    Abstract: The present invention provides methods for dispensing or distributing a drug, particularly a potentially teratogenic drug, to a patient while minimizing the occurrence of an adverse side effect. In particular, the present invention provides methods for dispensing or distributing a drug containing topiramate to a patient in need of weight loss to minimize the occurrence of potential birth defects associated with the drug. Methods for providing training to prescribers on the potential risks associated with particular drugs are also disclosed.
    Type: Application
    Filed: January 2, 2020
    Publication date: April 30, 2020
    Inventors: Michael MILLER, Barbara TROUPIN
  • METHODS OF PREVENTING PROGRESSION TO TYPE 2 DIABETES MELITUS
    Publication number: 20190201374
    Abstract: The present invention provides compositions and methods for delaying or preventing progression to type 2 diabetes mellitus in individuals with prediabetes and metabolic syndrome.
    Type: Application
    Filed: July 31, 2018
    Publication date: July 4, 2019
    Inventors: Wesley DAY, Barbara TROUPIN
  • METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS
    Publication number: 20190139635
    Abstract: The present invention provides methods for dispensing or distributing a drug, particularly a potentially teratogenic drug, to a patient while minimizing the occurrence of an adverse side effect. In particular, the present invention provides methods for dispensing or distributing a drug containing topiramate to a patient in need of weight loss to minimize the occurrence of potential birth defects associated with the drug. Methods for providing training to prescribers on the potential risks associated with particular drugs are also disclosed.
    Type: Application
    Filed: June 14, 2018
    Publication date: May 9, 2019
    Inventors: Michael MILLER, Barbara TROUPIN
  • Methods of preventing progression to type 2 diabetes mellitus
    Patent number: 10058532
    Abstract: The present invention provides compositions and methods for delaying or preventing progression to type 2 diabetes mellitus in individuals with prediabetes and metabolic syndrome.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: August 28, 2018
    Assignee: Vivus, Inc.
    Inventors: Wesley Day, Barbara Troupin
  • METHODS OF PREVENTING PROGRESSION TO TYPE 2 DIABETES MELLITUS
    Publication number: 20180055818
    Abstract: The present invention provides compositions and methods for delaying or preventing progression to type 2 diabetes mellitus in individuals with prediabetes and metabolic syndrome.
    Type: Application
    Filed: June 30, 2017
    Publication date: March 1, 2018
    Inventors: Wesley DAY, Barbara TROUPIN
  • METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS
    Publication number: 20180052975
    Abstract: The present invention provides methods for dispensing or distributing a drug, particularly a potentially teratogenic drug, to a patient while minimizing the occurrence of an adverse side effect. In particular, the present invention provides methods for dispensing or distributing a drug containing topiramate to a patient in need of weight loss to minimize the occurrence of potential birth defects associated with the drug. Methods for providing training to prescribers on the potential risks associated with particular drugs are also disclosed.
    Type: Application
    Filed: October 26, 2017
    Publication date: February 22, 2018
    Inventors: Michael MILLER, Barbara TROUPIN
  • Methods of preventing progression to type 2 diabetes mellitus
    Patent number: 9724327
    Abstract: The present invention provides compositions and methods for delaying or preventing progression to type 2 diabetes mellitus in individuals with prediabetes and metabolic syndrome.
    Type: Grant
    Filed: October 8, 2014
    Date of Patent: August 8, 2017
    Assignee: Vivus, Inc.
    Inventors: Wesley Day, Barbara Troupin
  • Methods of Preventing Progression to Type 2 Diabetes Mellitus
    Publication number: 20150099801
    Abstract: The present invention provides compositions and methods for delaying or preventing progression to type 2 diabetes mellitus in individuals with prediabetes and metabolic syndrome.
    Type: Application
    Filed: October 8, 2014
    Publication date: April 9, 2015
    Inventors: Wesley Day, Barbara Troupin
  • METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS
    Publication number: 20140288944
    Abstract: The present invention provides methods for dispensing or distributing a drug, particularly a potentially teratogenic drug, to a patient while minimizing the occurrence of an adverse side effect. In particular, the present invention provides methods for dispensing or distributing a drug containing topiramate to a patient in need of weight loss to minimize the occurrence of potential birth defects associated with the drug. Methods for providing training to prescribers on the potential risks associated with particular drugs are also disclosed.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 25, 2014
    Inventors: Michael MILLER, Barbara TROUPIN